<DOC>
	<DOCNO>NCT00725101</DOCNO>
	<brief_summary>The Real World Examination Fibromyalgia : Longitudinal Evaluation Costs Treatments ( REFLECTIONS ) Study 12-month , prospective observational study utilize approximately 58 care setting United States ( US ) Puerto Rico . It design examine treatment pattern health outcome adult participant diagnose physician fibromyalgia ( FM ) start `` new pharmacologic agent '' FM . The primary benefit study enhance understanding disease state FM role pharmacologic treatment play , may help optimize management FM . This study address current gap rapidly grow body literature FM .</brief_summary>
	<brief_title>Fibromyalgia Health Outcome Study Cost Treatments</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Meet criterion fibromyalgia ( FM ) opinion investigator Must prescribe 'new ' treatment FM Male female participant least 18 year age Willing complete Informed Consent Document ( ICD ) require form eligible study participation Currently care participate physician Cognitively able understand complete participant selfrated scale English Spanish via computerassisted telephone interview ( CATI ) Available 12 month participate study Are investigator site personnel directly affiliate study and/or immediate family . Immediate family define spouse , parent , child , sibling , whether biological legally adopt Are Lilly employee Are Terminally ill Currently participate research study begin research study participate study Unable respond via telephone CATI Incompetent interview deem participate physician Unwilling provide write ICD require form participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>